Patents by Inventor Terri F. Busch

Terri F. Busch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulations comprising an immune response modifier
    Patent number: 7968562
    Abstract: Pharmaceutical formulations comprising an immune response modifier (IRM) chosen from imidazoquinoline amines, imidazotetrahydroquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, thiazolo-quinolineamines, oxazolo-quinolinamines, thiazolo-pyridinamines, oxazolo-pyridinamines, imidazonaphthyridine amines, tetrahydroimidazonaphthyridine amines, and thiazolonaphthyridine amines; a fatty acid; and a hydrophobic, aprotic component miscible with the fatty acid are useful for the treatment of dermal associated conditions. Novel topical formulations are provided. In one embodiment, the topical formulations are advantageous for treatment of actinic keratosis, postsurgical scars, basal cell carcinoma, atopic dermatitis, and warts.
    Type: Grant
    Filed: July 14, 2008
    Date of Patent: June 28, 2011
    Assignee: 3M Innovative Properties Company
    Inventors: Raymond D. Skwierczynski, Terri F. Busch, Amy L. Gust-Heiting, Mary Fretland, Matthew T. Scholz
  • IMMUNE RESPONSE MODIFIER FORMULATIONS
    Publication number: 20100092401
    Abstract: The present invention provides a pharmaceutical foam formulation. Generally, the formulation includes a therapeutically effective amount of imiquimod and a fatty acid.
    Type: Application
    Filed: July 12, 2007
    Publication date: April 15, 2010
    Applicant: Graceway Pharmaceuticals, LLC
    Inventors: Janet A. Vallejo, Suzanne S. Leung, Patrick J. Roddy, Terri F. Busch
  • PHARMACEUTICAL FORMULATIONS COMPRISING AN IMMUNE RESPONSE MODIFIER
    Publication number: 20080275077
    Abstract: Pharmaceutical formulations comprising an immune response modifier (IRM) chosen from imidazoquinoline amines, imidazotetrahydroquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, thiazolo-quinolineamines, oxazolo-quinolinamines, thiazolo-pyridinamines, oxazolo-pyridinamines, imidazonaphthyridine amines, tetrahydroimidazonaphthyridine amines, and thiazolonaphthyridine amines; a fatty acid; and a hydrophobic, aprotic component miscible with the fatty acid are useful for the treatment of dermal associated conditions. Novel topical formulations are provided. In one embodiment, the topical formulations are advantageous for treatment of actinic keratosis, postsurgical scars, basal cell carcinoma, atopic dermatitis, and warts.
    Type: Application
    Filed: July 14, 2008
    Publication date: November 6, 2008
    Inventors: Raymond D. Skwierczynski, Terri F. Busch, Amy L. Gust-Heiting, Mary Fretland, Matthew T. Scholz
  • Pharmaceutical formulation comprising an immune response modifier
    Publication number: 20030199538
    Abstract: Pharmaceutical formulations comprising an immune response modifier (IRM) chosen from imidazoquinoline amines, imidazotetrahydroquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, thiazolo-quinolineamines, oxazolo-quinolinamines, thiazolo-pyridinamines, oxazolo-pyridinamines, imidazonaphthyridine amines, tetrahydroimidazonaphthyridine amines, and thiazolonaphthyridine amines; a fatty acid; and a hydrophobic, aprotic component miscible with the fatty acid are useful for the treatment of dermal associated conditions. Novel topical formulations are provided. In one embodiment, the topical formulations are advantageous for treatment of actinic keratosis, postsurgical scars, basal cell carcinoma, atopic dermatitis, and warts.
    Type: Application
    Filed: November 27, 2002
    Publication date: October 23, 2003
    Applicant: 3M Innovative Properties Company
    Inventors: Raymond D. Skwierczynski, Terri F. Busch, Amy L. Gust-Heiting, Mary Fretland, Matthew T. Scholz
  • Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
    Patent number: 6486168
    Abstract: Immune response modifier (IRM) compounds—imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, thiazolo- and oxazolo-quinolinamines and pyridinamines, imidazonaphthyridine and tetrahydroimidazonaphthyridine amines—are useful for the treatment of conditions at and below the mucosal surfaces by administering a therapeutically effective amount of such compounds to the mucosal surface. Novel pharmaceutical formulations are provided. In one embodiment, the pharmaceutical formulations are advantageous for treatment of cervical conditions such as cervical dysplasias including cervical intraepithelial neoplasias.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: November 26, 2002
    Assignee: 3M Innovative Properties Company
    Inventors: Raymond D. Skwierczynski, Kenneth R. Phares, Richard L. Miller, Zheng Jane Li, Michael J. Jozwiakowski, Terri F. Busch
  • Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
    Patent number: 6245776
    Abstract: Immune response modifier (IRM) compounds—imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, thiazolo- and oxazolo-quinolinamines and pyridinamines, imidazonaphthyridine and tetrahydroimidazonaphthyridine amines—are useful for the treatment of conditions at and below the mucosal surfaces by administering a therapeutically effective amount of such compounds to the mucosal surface. Novel pharmaceutical formulations are provided. In one embodiment, the pharmaceutical formulations are advantageous for treatment of cervical conditions such as cervical dysplasias including cervical intraepithelial neoplasias.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: June 12, 2001
    Assignee: 3M Innovative Properties Company
    Inventors: Raymond D. Skwierczynski, Kenneth R. Phares, Richard L. Miller, Zheng Jane Li, Michael J. Jozwiakowski, Terri F. Busch